Patients consistently see progress when they follow a program that balances science with ongoing care
If additional glycemic control is needed, the dose may be increased to 1 mg weekly after at least four weeks, and potentially to a maximum of 2 mg weekly
GLP-1 therapy, which stands for glucagon-like peptide-1, is a treatment option increasingly used to help control blood sugar levels in people with type 2 diabetes
Glutathiones antioxidant, photoprotective, and collagen-boosting properties make it an effective component in anti-aging skin care, helping to repair fine lines, wrinkles, loss of elasticity, and dullness
While Wegovy semaglutide tablets are now MHRA-approved (11 June 2026), they are not yet commercially available
Before starting or continuing both medications together, ensure you discuss: Your Complete Medical History: Previous or current mental health conditions, including depression, anxiety, bipolar disorder, or suicidal ideation History of seizures or conditions that lower seizure threshold Eating disorders (past or present) Cardiovascular disease, including hypertension Kidney or liver impairment Thyroid disorders Diabetes and current glycaemic control Gastrointestinal conditions, including pancreatitis or gallbladder disease Eligibility for Wegovy under NICE guidelines (typically requiring specialist weight management services, specific BMI thresholds, and other criteria) All Current Medications: Provide a complete list including: Prescription medications (especially anticoagulants like warfarin, antidiabetic drugs, or medications affecting seizure threshold such as tramadol, antipsychotics, tricyclic antidepressants, or quinolone antibiotics) Medications that affect CYP2B6 enzymes which metabolise bupropion Over-the-counter medicines Herbal supplements and vitamins Recreational substances or alcohol use Treatment Goals and Monitoring: Discuss realistic expectations for weight management and smoking cessation
